References
- Pavlou AK Reichert JM . Recombinant protein therapeutics-success rates, market trends and values to 2010. Nat. Biotech22 (12), 1513–1519 (2004).
- Kivitz A Cohen S Dowd JE et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin. Ther.28 (10), 1619–1629 (2006).
- Mack GS . Pfizer dumps Exubera. Nat. Biotech.25 (12), 1331–1332 (2007).
- Sullivan SP Koutsonanos DG Del Pilar Martin M et al. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med.16 (8), 915–920 (2010).
- Cormier M Johnson B Ameri M et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control Release97 (3), 503–511 (2004).
- Banga AK . Microporation applications for enhancing drug delivery. Expert Opin. Drug Deliv.6 (4), 343–354 (2009).
- Vaxxas Nanopatch . www.vaxxas.com
- Zosano Pharma-ZP-PTH . www.zosanopharma.com
- Daddona PE Matriano JA Mandema J Maa YF . Parathyroid hormone (1–34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res.28 (1), 159–165 (2011).
- Wang L Venkatraman S Kleiner L . Drug release from injectable depots: two different in vitro mechanisms. J. Control Release99 (2), 207–216 (2004).
- Lim SG Ameenuddin S Burnett JC Jr Venkatraman SS Chen HH . Sustained delivery of a novel natriuretic peptide for three weeks with in situ polymer precipitation delivery system. J. Card. Fail.18 (8), S63 (2012).
- Durect . www.durect.com